EDTXF.US Spectral Med Inc

Healthcare Biotechnology USA Stocks
0.7300 USD
Close of Nov 14, 2026
0.6380 1.10
Market cap
USD 214M
P/E
-
P/B
52.12x
ROE
-
Dividend yield
-
Fundamental score
-

Ratios use the latest price and the current fiscal year annualized from 3 quarters up to Sep 2026.

Is EDTXF.US undervalued?

Graham number

The Graham number of Spectral Med Inc cannot be estimated reliably (it needs positive earnings and book value).

Graham number = √(22.5 × EPS × book value per share): the most a defensive investor should pay according to Benjamin Graham. An estimate, not a recommendation to buy or sell. How is it calculated?

Spectral Med Inc fundamental analysis

No fundamental analysis for Spectral Med Inc yet.

Spectral Med Inc stock price

Prices on the chart can differ slightly from the closing prices StockSummer uses for its ratios.

About Spectral Med Inc

Spectral Medical Inc. focuses on the development and commercialization of products for the treatment of septic shock in the United States, Italy, Ireland, Russia, and internationally. The company markets Endotoxin Activity Assay, a rapid in-vitro diagnostic test for the detection of components of gram negative; and Polymyxin B-Hemoperfusion, a therapeutic hemoperfusion device that removes endotoxin from the bloodstream. It also develops, manufactures, and markets monoclonal …

Full company profile